Phibro Animal Health Operating Expenses 2012-2024 | PAHC

Phibro Animal Health operating expenses from 2012 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Phibro Animal Health Operating Expenses 2012-2024 | PAHC

Phibro Animal Health operating expenses from 2012 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$202.6B
Stryker (SYK)$144.4B
Boston Scientific (BSX)$130.4B
Medtronic (MDT)$113.2B
EssilorLuxottica (ESLOY)$112.1B
Lonza Group Ag (LZAGY)$45.3B
Haleon (HLN)$43B
GE HealthCare Technologies (GEHC)$39B
ResMed (RMD)$36.5B
Terumo (TRUMY)$30.6B
Koninklijke Philips (PHG)$24.9B
Zimmer Biomet Holdings (ZBH)$21.8B
Insulet (PODD)$19.3B
Baxter (BAX)$17.5B
Smith & Nephew SNATS (SNN)$10.8B
Bio-Rad Laboratories (BIO)$10.2B
BellRing Brands (BRBR)$9.2B
Demant (WILYY)$8.4B
Lantheus Holdings (LNTH)$5.8B
TG Therapeutics (TGTX)$4.8B
Haemonetics (HAE)$4.6B
ICU Medical (ICUI)$4.4B
Prestige Consumer Healthcare (PBH)$4B
Perrigo (PRGO)$3.6B
Envista Holdings (NVST)$3.6B
Neogen (NEOG)$3.6B
Agios Pharmaceuticals (AGIO)$3.4B
GN Store Nord (GNNDY)$3.1B
Shandong Weigao Medical Polymer (SHWGF)$3B
QuidelOrtho (QDEL)$2.9B